PT  - JOURNAL ARTICLE
AU  - Jarey H. Wang
AU  - Lance McCoy
AU  - Vivian Salama
AU  - Temitayo Ajayi
AU  - Cem Dede
AU  - Amy C. Moreno
AU  - Abdallah S.R. Mohamed
AU  - Katherine A. Hutcheson
AU  - Clifton David Fuller
AU  - Lisanne V. van Dijk
AU  - MD Anderson Symptom Working Group
TI  - Sub-acute post-treatment dysphagia and shortness-of-breath symptom severity associates with survival and disease control in oropharyngeal cancer patients
AID  - 10.1101/2022.08.24.22279166
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.08.24.22279166
4099  - http://medrxiv.org/content/early/2022/08/24/2022.08.24.22279166.short
4100  - http://medrxiv.org/content/early/2022/08/24/2022.08.24.22279166.full
AB  - Importance Post-treatment symptoms are a focal point of follow-up visits for head and neck cancer (HNC) patients. While symptoms such as dysphagia and shortness-of-breath early after treatment may motivate additional work up, their precise association with disease control and survival outcomes is not well established.Objective To investigate the associations between patient-reported swallowing, choking and shortness-of-breath symptoms at 3-to-6 months following radiotherapy and overall survival and disease control.Design Cohort study with prospectively collected symptom scores. Associations between the presence of moderate-to-severe swallowing, choking and mild-to-severe shortness-of-breath and treatment outcome were analyzed with Cox regression and Kaplan-Meier analyses.Setting Prospective symptom and outcome registry from single academic cancer referral center.Participants Consented sequential oropharyngeal cancer (OPC) patients with pathologically confirmed squamous cell carcinoma with known symptom scores at the 3–6-month follow-up after radiotherapy.Main Outcome(s) and Measure(s) The main outcomes were overall survival (OS), and the secondary endpoints were local (LC), regional (RC), and distant disease control (DC). The potential predictors were post-treatment symptoms: patient-rated swallowing, choking and shortness-of-breath at 3-to-6 months after completion of radiotherapy.Results Symptom scores at 3-to-6 months were collected for 470 patients. The majority (91.3%) were HPV-positive. Median follow-up time was 31.7 months (IQR: 21.9-42.1). Univariable Cox regression showed significant associations between OS and all three symptoms of swallowing, choking, and shortness-of-breath (p<0.0092). Furthermore, a composite variable integrating scores of all three symptoms had the best predictive value for OS (c-index=0.75 [0.60-0.90]). Univariable analysis demonstrated that swallowing (HR=19.52 95% CI: [3.57-106.79]) and choking (HR=11.19 [2.05-61.25]) symptoms were significantly associated with LC, no symptoms were associated with RC, and choking (HR=5.11 [1.71-15.25]) and shortness-of-breath (HR=3.94 [1.44-10.78]) were associated with DC. The same significant associated for OS were also seen for HPV-positive only subset analysis (p<0.01 for all symptoms).Conclusions and Relevance Quantitative early patient-reported measures of dysphagia and shortness-of-breath are significant predictors of OS and disease recurrence/progression in OPC patients. This was also observed for HPV-positive OPC only. Integrating quantitative post-treatment symptom surveys may guide individualized follow-up strategies to intensify or deintensify tumor surveillance.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialPA14-0947 data collection, PA11-0809 analysisFunding StatementDirect infrastructure support is provided by the multidisciplinary Stiefel Oropharyngeal Research Fund of the University of Texas MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer, and the NIH/NCI Grant (P30CA016672). Dr. van Dijk, received/receives funding and salary support from the Dutch organization NWO ZonMw during the period of study execution via the Rubicon Individual career development grant. Dr. Hutcheson, Mohamed, and Fuller received/receives funding and salary support unrelated to this project during the period of study execution from: the NIH National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (R01CA218148). Dr. Mohamed, and Fuller received/receives funding and salary support unrelated to this project during the period of study execution from: the National Institutes of Health (NIH) National Institute for Dental and Craniofacial Research (NIDCR) Establishing Outcome Measures Award (R01DE025248/R56DE025248). Mr. McCoy is funded by NIH Research Supplements to Promote Diversity in Health-Related Research (R01DE025248-S02). Dr. Fuller received funding unrelated to this project during the period of study execution from NIH/NCI Cancer Center (P30CA016672, P50 CA097007, and R01CA2148250); from NIH/NIBIB (R25EB025787-01); from NIH/NSF (NSF1557679); NSF-CMMI grant (NSF1933369); and the Sabin Family Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of of The University of Texas MD Anderson Cancer Center (MDACC) gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors